Please Wait
Applying Filters...
menu
    • menu
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    EuroAPI Treprostinil Diolamine

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    An Enquiry

    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Aspen API. More than just an API™

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    An Enquiry

    Menu

    Treprostinil Diolamine

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 5United Therapeutics

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    PharmaCompass
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    01

    United Therapeutics

    U.S.A
    India Pharma Expo
    Not Confirmed
    arrow

    United Therapeutics

    U.S.A
    arrow
    India Pharma Expo
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : RX

    Registration Country : USA

    TREPROSTINIL DIOLAMINE

    Brand Name : ORENITRAM

    Dosage Form : TABLET, EXTENDED RELEASE;ORAL

    Dosage Strength : EQ 0.125MG BASE

    Packaging :

    Approval Date : 2013-12-20

    Application Number : 203496

    Regulatory Info : RX

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    United Therapeutics

    U.S.A
    India Pharma Expo
    Not Confirmed
    arrow

    United Therapeutics

    U.S.A
    arrow
    India Pharma Expo
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : RX

    Registration Country : USA

    TREPROSTINIL DIOLAMINE

    Brand Name : ORENITRAM

    Dosage Form : TABLET, EXTENDED RELEASE;ORAL

    Dosage Strength : EQ 0.25MG BASE

    Packaging :

    Approval Date : 2013-12-20

    Application Number : 203496

    Regulatory Info : RX

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    United Therapeutics

    U.S.A
    India Pharma Expo
    Not Confirmed
    arrow

    United Therapeutics

    U.S.A
    arrow
    India Pharma Expo
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : RX

    Registration Country : USA

    TREPROSTINIL DIOLAMINE

    Brand Name : ORENITRAM

    Dosage Form : TABLET, EXTENDED RELEASE;ORAL

    Dosage Strength : EQ 1MG BASE

    Packaging :

    Approval Date : 2013-12-20

    Application Number : 203496

    Regulatory Info : RX

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    United Therapeutics

    U.S.A
    India Pharma Expo
    Not Confirmed
    arrow

    United Therapeutics

    U.S.A
    arrow
    India Pharma Expo
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : RX

    Registration Country : USA

    TREPROSTINIL DIOLAMINE

    Brand Name : ORENITRAM

    Dosage Form : TABLET, EXTENDED RELEASE;ORAL

    Dosage Strength : EQ 2.5MG BASE

    Packaging :

    Approval Date : 2013-12-20

    Application Number : 203496

    Regulatory Info : RX

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    United Therapeutics

    U.S.A
    India Pharma Expo
    Not Confirmed
    arrow

    United Therapeutics

    U.S.A
    arrow
    India Pharma Expo
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : RX

    Registration Country : USA

    TREPROSTINIL DIOLAMINE

    Brand Name : ORENITRAM

    Dosage Form : TABLET, EXTENDED RELEASE;ORAL

    Dosage Strength : EQ 5MG BASE

    Packaging :

    Approval Date : 2016-10-07

    Application Number : 203496

    Regulatory Info : RX

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.